Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
E
Show more
Class 5: Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradat…
Class 9: Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databa…
Class 40: Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid
Class 42: Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABD…
Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 40 – Materials treatmentClass 42 – Technology & SaaS
Status timeline
- 14 Jul 2022Application filedNew Application Entered
- 25 Apr 2023Assigned to an examining attorneyAssigned To Examiner
- 27 Apr 2023Office action issuedNon-Final Action Written
- 26 Jun 2023Response to office action filedTeas Response To Office Action Received
- 7 Jan 2024Approved for publicationApproved For Pub - Principal Register
- 13 Feb 2024Published for oppositionPublished For Opposition
- 9 Apr 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 25 Feb 2025Registered on the Principal RegisterRegistered-Principal Register
- 10 Jun 2026Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
All 27 events
| 2026-06-10 | Automatic Update Of Assignment Of Ownership |
| 2025-02-25 | Registered-Principal Register |
| 2025-02-25 | Notice Of Registration Confirmation Emailed |
| 2024-10-09 | Notice Of Allowance Cancelled |
| 2024-10-09 | 1(B) Basis Deleted; Proceed To Registration |
| 2024-09-26 | Teas Delete 1(B) Basis Received |
| 2024-04-09 | Noa Mailed - Sou Required From Applicant |
| 2024-02-13 | Published For Opposition |
| 2024-02-13 | Official Gazette Publication Confirmation E-Mailed |
| 2024-01-24 | Notification Of Notice Of Publication E-Mailed |
| 2024-01-07 | Approved For Pub - Principal Register |
| 2024-01-05 | Examiners Amendment -Written |
| 2024-01-05 | Examiners Amendment E-Mailed |
| 2024-01-05 | Notification Of Examiners Amendment E-Mailed |
| 2024-01-05 | Examiner's Amendment Entered |
| 2023-11-30 | Assigned To Lie |
| 2023-11-30 | Correspondence Received In Law Office |
| 2023-11-30 | Teas/Email Correspondence Entered |
| 2023-06-26 | Teas Response To Office Action Received |
| 2023-04-27 | Non-Final Action Written |
| 2023-04-27 | Non-Final Action E-Mailed |
| 2023-04-27 | Notification Of Non-Final Action E-Mailed |
| 2023-04-25 | Assigned To Examiner |
| 2023-04-19 | Teas Voluntary Amendment Received |
| 2022-07-30 | Notice Of Design Search Code E-Mailed |
| 2022-07-29 | New Application Office Supplied Data Entered |
| 2022-07-14 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradat…
Class 9 Software, electronics & scientific
Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databa…
Class 40 Materials treatment
Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid
Class 42 Technology & SaaS
Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABD…
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 11 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.